Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

International Survey of Acute Coronavirus Syndromes (ISACS)-COVID-19

ID
Name
ISACS-COVID-19
Description
In response to the COVID-19 crisis, ISACS-TC has promoted a new registry of the existing and further centers of the same geographic areas to support clinical research to prevent, and treat the COVID-19 illness. These efforts are made possible by the generous contributions of clinical research volunteers in some of the countries participating to the prior acute coronary syndrome network.
Trial arms
Trial start
2021-12-01
Estimated PCD
2024-12-31
Trial end
2024-12-31
Status
Recruiting
Treatment
Observational (registry)
Observational (Patient Registry)
Arms:
Diabetes, Dyslipidemias, Elderly, Female, Heart Diseases, Hypertension, Kidney Disease, Male, Smoking, Vascular diseases
Size
10000
Primary endpoint
Death all cause
30-day
Death all cause
6 month
Death all cause
12-month
Eligibility criteria
Inclusion Criteria: * Age ≥18 years (male or female) * Patients admitted to any hospital center with a confirmed diagnosis of COVID-19 infection. Exclusion Criteria: • Underage or not able to give informed consent
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': True, 'targetDuration': '1 Year', 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'CROSS_SECTIONAL'}, 'bioSpec': {'retention': 'SAMPLES_WITH_DNA', 'description': 'Databases with significant genomic data (e.g., genome-wide association studies, medical sequencing, molecular diagnostic assays), are expected to be deposited as well. Likewise, physical bio-samples can be included in the ISACS-COVID-19 registry'}, 'enrollmentInfo': {'count': 10000, 'type': 'ESTIMATED'}}
Updated at
2024-05-07

1 organization

1 product

1 indication

Organization
University of Bologna
Product
Observational
Indication
COVID-19